Need Help?

Whole exome sequencing (WES) of EBV- primary central nervous system lymphoma (PCNSL)

This dataset contains whole exome sequencing (WES) of 29 HIV- EBV- primary central nervous system lymphoma (PCNSL) tumors and 5 activated B-cell-like PCNSL (ABC-PCNSL) and activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) cell lines (TK, HKBML, OCI-Ly3, HBL-1, TMD-8). Cases with secondary involvement of the CNS were excluded. DNA was extracted with AllPrep DNA/RNA FFPE kit and libraries were prepared using the Agilent SureSelect Human All Exon v6 + UTR kit. Paired end reads were aligned to GRCh37 using bwa mem v.0.7.17, and reads were sorted and duplicated were marked in the final BAM files. Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

Request Access

DUO:0000012
version: 2021-02-23

research specific restrictions

This data use modifier indicates that use is limited to studies of a certain research type.

DUO:0000014
version: 2019-01-07

research use only

This data use limitation indicates that use is limited to research purposes (e.g., does not include its use in clinical care).

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

BC Cancer, part of the Provincial Health Services Authority - Data Access Policy

Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000000312 Exome Sequencing

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF00008426757 bam 17.5 GB Report
EGAF00008426760 bam 11.8 GB Report
EGAF00008426764 bam 15.7 GB Report
EGAF00008426770 bam 10.6 GB Report
EGAF00008426773 bam 7.4 GB Report
EGAF00008426776 bam 9.2 GB Report
EGAF00008426781 bam 16.0 GB Report
EGAF00008426784 bam 17.4 GB Report
EGAF00008426787 bam 19.8 GB Report
EGAF00008426789 bam 14.3 GB Report
EGAF00008426793 bam 10.2 GB Report
EGAF00008426794 bam 11.6 GB Report
EGAF00008426797 bam 12.3 GB Report
EGAF00008426800 bam 12.4 GB Report
EGAF00008426803 bam 12.8 GB Report
EGAF00008426808 bam 12.5 GB Report
EGAF00008426814 bam 14.8 GB Report
EGAF00008426817 bam 12.4 GB Report
EGAF00008426821 bam 11.3 GB Report
EGAF00008426823 bam 16.8 GB Report
EGAF00008426824 bam 11.1 GB Report
EGAF00008426828 bam 15.7 GB Report
EGAF00008426832 bam 18.5 GB Report
EGAF00008426835 bam 16.9 GB Report
EGAF00008426838 bam 13.7 GB Report
EGAF00008426840 bam 14.2 GB Report
EGAF00008426843 bam 14.9 GB Report
EGAF00008426847 bam 16.3 GB Report
EGAF00008426850 bam 16.0 GB Report
EGAF00008426851 bam 11.6 GB Report
EGAF00008426855 bam 9.9 GB Report
EGAF00008426857 bam 10.1 GB Report
EGAF00008426860 bam 10.5 GB Report
EGAF00008427033 bam 9.8 GB Report
34 Files (456.3 GB)